Aligos Therapeutics Inc
Search For a Symbol
Aligos Therapeutics Inc Stock, NASDAQ:ALGS
1 Corporate Drive, 2nd floor, South San Francisco, California 94080
United States of America
Number of Employees: 83
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is engaged in in developing therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). The company was founded by Lucinda Quan and Lawrence M. Blatt on February 05, 2018 and is headquartered in South San Francisco, CA.